NEW YORK, Oct. 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Adeptus Health Inc. (“Adeptus”) (NYSE:ADPT) pursuant and/or traceable to the Company’s secondary public offering on or about July 31, 2015, and purchasers of common shares between April 23, 2015 and November 16, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas. If you purchased or otherwise acquired Adeptus securities pursuant to the SPO or between April 23, 2015 and November 16, 2015, your rights may be affected by this action. To get more information go to:
http://www.zlk.com/pslra/adeptus-health
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that Adeptus made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was engaging in predatory billing practices, thus exposing Adeptus to numerous risks and possible penalties, including civil and/or criminal sanctions, and exclusion from federal and/or state healthcare programs; (ii) Adeptus’ financial statements had not been prepared in conformity with generally accepted accounting principles; and (iii) contrary to representations about Adeptus’ practice of referring lower acuity patients to urgent care facilities, it routinely treated and excessively billed these patients.
If you suffered a loss in Adeptus Health you have until December 27, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 



